17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

Clinical trial NCT00098488 · TERMINATED

Trial details

NCT number

NCT00098488

Sponsor

National Cancer Institute (NCI)

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2005-04-01

Primary completion

2008-04-01

Enrollment

30

View on ClinicalTrials.gov